Stage 0 Breast CancerCancer of the Breast Tisdoi:10.1007/978-3-540-85516-3_1259Springer Berlin HeidelbergSpringer Berlin Heidelberg
Examining the distribution of breast cancer (BC) stage and molecular subtype among women aged below (< 45 years), within (45–65
来自 Semantic Scholar 喜欢 0 阅读量: 58 作者:G Vanagas,A Mickeviciene,A Ulys 摘要: The lack of consensus amongst experts delineate how important it is for patients diagnosed with prostate cancer (PCa) to make an informed decision on available treatment options through an objective discussion of...
Caregiver Burden in End-Stage Ovarian Cancer Background: Caregiver burden associated with caring for women with ovarian cancer has received limited focus. However, these patients often have complex ne... J Hartnett,B Thom,N Kline - 《Clinical Journal of Oncology Nursing》 被引量: 0发表: 2016...
Advanced stage mucinous epithelial ovarian cancer: the Hellenic cooperative oncology group experience. Gynecol Oncol. 2005;97(2):436–41. https://doi.org/10.1016/j.ygyno.2004.12.056. Article PubMed Google Scholar Download references Acknowledgments Authors declare that there is neither financial ...
Diana Sarfati1 and James Stanley1 1Department of Public Health, University of Otago, PO Box 7343, Wellington, New Zealand Background: It is known that cancer stage is affected by comorbidity, but the evidence regarding the magnitude and even direction of this effect is highly inconsistent and ...
Breast-contour preserving procedures for early-stage breast cancer: a population-based study of the trends, variation in practice and predictive characteristics... E Heeg,MB Jensen,MAM Mureau,... - 《Breast Cancer Research & Treatment》 被引量: 0发表: 2020年 Trends in surgery and adjuvant trea...
被引量: 0发表: 2020年 Phase I Trial of Concurrent Weekly CPT-11, Cisplatinum, and Radiotherapy for Patients with Newly Diagnosed Stage IIIb - IVa Cancer of the Uterine Cervix To investigate and analyze the value of image-guided precise radiotherapy for cervical cancer. From January 2016 to De...
Objectives To assess the value of additional research for ERCC1 expression testing to guide adjuvant chemotherapy decisions in fully resected Stage I non-small cell lung cancer (NSCLC). Methods We refined a previously-developed decision-analytic model to estimate the expected value of perfect informati...
We report on the results of a phase II clinical trial of Panagen (tablet form of fragmented human DNA preparation) in breast cancer patients (placebo groupn= 23, Panagenn= 57). Panagen was administered as an adjuvant leukoprotective agent in FAC and AC chemotherapy regimens. Pre-clinica...